3B-U0098 - sulfisoxazole | 127-69-5

Sulfonamides used as drugs

Sulfisoxazole: a short-acting antibacterial targeting gram-positive/negative bacteria and inhibits breast cancer exosome by affecting endothelin receptor A.

Sulfisoxazole

Sulfisoxazole is an antimicrobial agent that belongs to the group of sulfa drugs. It is a prodrug that is hydrolyzed in vivo to its active form, sulfadiazine. Sulfisoxazole has been shown to cause neuronal death in rats, with the reaction mechanism being related to its ability to react with sulfhydryl groups on enzymes involved in neurotransmission and cell metabolism. Sulfisoxazole also has high resistance against most bacteria, making it an ideal drug for wastewater treatment and analytical methods. In addition, sulfisoxazole has been shown to have physiological effects such as lowering blood sugar levels and inhibiting erythrocyte aggregation.

Sulfisoxazole (Standard) is the standard substance of Sulfisoxazole, and it is applicable for quantitative analysis, quality control, and related research in biochemical experiments. Sulfisoxazole (Sulfafurazole) is a short-acting sulfonamide antibacterial with activity against a wide range of gram-negative and gram-positive organisms.Sulfisoxazole inhibits breast cancer exosome release by targeting endothelin receptor A.

SULFAFURAZOLE CRS